Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-20 Sale | 2024-05-20 8:04 pm | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 109,245 | $0 | $0 | 0 (Indirect Direct) | View |
| 2023-12-28 Sale | 2023-12-29 7:32 pm | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 1,016 | $20.04 | $20,362 | 2,875,108 (Indirect Direct) | View |
| 2023-12-22 Sale | 2023-12-27 9:07 pm | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 91,884 | $20.25 | $1,860,528 | 3,130,889 (Indirect Direct) | View |
| 2023-12-19 Sale | 2023-12-21 7:34 pm | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 2,402 | $20.01 | $48,064 | 2,641,207 (Indirect Direct) | View |
| 2023-12-08 Sale | 2023-12-12 9:02 pm | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 118,000 | $17.27 | $2,037,837 | 2,643,609 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-04 Option Award | 2026-08-06 5:17 pm | N/A 2036-08-03 | Attovia Therapeutics Inc. | ATTO | GOLD MITCHELL Director | 27,000 | $0 | 27,000 (Direct) | View |
Ownership | 2026-08-04 7:31 pm | N/A 2034-06-28 | Attovia Therapeutics Inc. | ATTO | GOLD MITCHELL Director | 0 | $0 | 72,765 (Direct) | View |
| 2024-05-18 Equity Swap | 2024-05-20 8:04 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 2,627,157 | $0 | 0 (Indirect) | View |
| 2024-05-08 Exercise | 2024-05-10 7:24 pm | N/A 2033-01-03 | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 13,245 | $0 | 3,073,157 (Direct) | View |
| 2024-05-08 Exercise | 2024-05-10 7:24 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 13,245 | $7.55 | 3,073,157 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-05 6:08 pm | N/A 2034-01-03 | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 336,000 | $0 | 2,963,157 (Direct) | View |
| 2023-12-28 Exercise | 2023-12-29 7:32 pm | N/A 2027-03-13 | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 75,457 | $0 | 2,875,108 (Direct) | View |
| 2023-12-28 Exercise | 2023-12-29 7:32 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 74,441 | $12.74 | 2,875,108 (Indirect) | View |
| 2023-12-28 Exercise | 2023-12-29 7:32 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 1,016 | $0.65 | 2,875,108 (Direct) | View |
| 2023-12-28 Tax Withholding | 2023-12-29 7:32 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 48,264 | $19.65 | 2,875,108 (Indirect) | View |
| 2023-12-22 Exercise | 2023-12-27 9:07 pm | N/A 2025-12-15 | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 91,884 | $0 | 3,130,889 (Direct) | View |
| 2023-12-22 Exercise | 2023-12-27 9:07 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 40,227 | $0.45 | 3,130,889 (Direct) | View |
| 2023-12-26 Exercise | 2023-12-27 9:07 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 51,657 | $0.65 | 3,130,889 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 7:34 pm | N/A 2025-12-15 | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 2,402 | $0 | 2,641,207 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 7:34 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 2,402 | $0.45 | 2,641,207 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-12 9:02 pm | N/A 2025-12-15 | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 8,613 | $0 | 2,643,609 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-12 9:02 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 8,613 | $0.45 | 2,643,609 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-05 7:04 pm | N/A 2033-01-03 | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO | 350,000 | $0 | 350,000 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-06 6:03 pm | N/A 2032-01-03 | ALPINE IMMUNE SCIENCES INC. | ALPN | GOLD MITCHELL Executive Chairman and CEO 10% Owner | 215,000 | $0 | 215,000 (Direct) | View |